Where does Hutchison Medipharma Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Hutchison Medipharma Limited ranks #10,350 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Hutchison Medipharma Limited hold?

Hutchison Medipharma Limited holds 30 US utility patents granted between 2015 and 2025, spanning 9 technology areas.

What is Hutchison Medipharma Limited's Innovation Score?

Hutchison Medipharma Limited has an Innovation Score of 44.1 out of 100 (top 27% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Hutchison Medipharma Limited focus on?

Hutchison Medipharma Limited's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 29 patents, ranking #678 of 6,058 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Hutchison Medipharma Limited's patent grant rate increasing or decreasing?

Hutchison Medipharma Limited's recent grant velocity is +7% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Hutchison Medipharma Limited's patents?

Hutchison Medipharma Limited's patents average 16.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Hutchison Medipharma Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Hutchison Medipharma Limited

USPTO PatentsView assignee record - 30 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Hutchison ranks #10,350 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 9 technology areas.

#10,350
of 49,997 US assignees by volume: Top 27%
by Innovation Score (44.1/100): 16.9
avg claims per patent: +7%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10350 · Foreign Corporation #10,350 · 30 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 30 grants
UPPER-Q #10,350/49,997
PHOTO-FINISH Hangzhou Dianzi…
CPC-NARROW A61P · 9 areas
INNOV-PAR 44.1/100
CLAIMS-RICH 16.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +7% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hangzhou Dianzi University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Hutchison’s 44.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.9 pts (27%) Velocity 11.4 pts (26%) Breadth 10.6 pts (24%) Claim depth 10.2 pts (23%)

Qualcomm Incorporated · highest

85
Ambiq Micro · near

44
Hutchison Medipharma · this assignee

44
Qualys · near

44
Universidad DE… · near

44
UNIVERSITÄT… · near

44
3D Lighting… · lowest

7

What this shows Hutchison's Innovation Score is 44.1/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Hutchison?

Each dot is one of Hutchison’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Hutchison’s own 16.9 claims/patent is ABOVE the 11.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Hutchison vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Hutchison's grants concentrate

Hutchison Medipharma Limited is a focused PatentsView assignee: 9 CPC subclasses with 96.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2024 (7 grants) versus a trough of 1 in 2017. By volume, Hutchison sits between Hongik University Industry-academia Cooperation Foundation and Included Health, Inc..

Hutchison's three-year grant acceleration

Hutchison Medipharma Limited shows 12 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Hongik University…

30
Horiba Advanced T…

30
Hubspot

30
Hudson Furniture

30
Hvrt

30
Hangzhou Dianzi U…

30
Hettich-oni & KG

30
Included Health

30
Hutchison Medipha… ◀

30

What this shows Hutchison holds 30 patents at rank #10,348, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Hutchison

By rank, the assignees closest to #10,348 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Hutchison's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Hutchison, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Hutchison ranks #678 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Universidad DE Santiago DE Chile 44 UNIVERSITÄT Duisburg-essen 44 Qualys, Inc. 44 Ambiq Micro, Inc. 44

Hutchison's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Hutchison Medipharma Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	13.3%
2016	2	6.7%
2017	1	3.3%
2018	3	10.0%
2019	4	13.3%
2020	1	3.3%
2021	2	6.7%
2022	3	10.0%
2023	2	6.7%
2024	7	23.3%
2025partial year	1	3.3%

Which technologies does Hutchison Medipharma Limited patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 29

C07D - Heterocyclic Compounds 29

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 19

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 11

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 4

C07C - Acyclic OR Carbocyclic Compounds 2

C07K - Peptides 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Hutchison Medipharma Limited's patent record in context - here's where to go next.

Hutchison Medipharma Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 96.7% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #10,350 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Hutchison Medipharma Limited against Hongik University Industry-academia Cooperation Foundation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.